1005180-36-8Relevant articles and documents
Discovery of BMS-753426: A Potent Orally Bioavailable Antagonist of CC Chemokine Receptor 2
Yang, Michael G.,Xiao, Zili,Zhao, Rulin,Tebben, Andrew J.,Wang, Bei,Cherney, Robert J.,Batt, Douglas G.,Brown, Gregory D.,Cvijic, Mary Ellen,Duncia, John V.,Gallela, Michael A.,Gardner, Daniel S.,Khandelwal, Purnima,Malley, Mary F.,Pang, Jian,Rose, Anne V.,Santella, Joseph B.,Sarjeant, Amy A.,Xu, Songmei,Mathur, Arvind,Mandlekar, Sandhya,Vuppugalla, Ragini,Zhao, Qihong,Carter, Percy H.
, p. 969 - 975 (2021)
To improve the metabolic stability profile of BMS-741672 (1a), we undertook a structure-activity relationship study in our trisubstituted cyclohexylamine series. This ultimately led to the identification of 2d (BMS-753426) as a potent and orally bioavaila